Pepticom

About Pepticom

Pepticom is a company focused on transforming medicine by improving access to novel peptide therapeutics. Their mission is to redefine peptide drug discovery using AI to explore uncharted chemical spaces, rapidly discovering new drug candidates with superior drug-like properties for previously undruggable targets and unmet medical needs.

Products & Services

AI-driven Peptide Drug Discovery Platform:A proprietary computational AI platform that uses reinforcement learning, ultra-fast algorithms, and structural data integration to design and optimize novel therapeutic peptides. It navigates vast peptide spaces (10⁸⁰ possibilities) using natural and non-natural amino acids to create drug candidates with enhanced stability, efficacy, and bioavailability.

In-House Development Program:Focused on developing novel oral IL-17 inhibitors for Plaque Psoriasis treatment, believed to be the world's first AI-designed therapeutic peptide for psoriasis. Currently in the lead optimization phase, with plans to announce the first drug candidate in 2025.

Collaborations:Pepticom collaborates with external partners to design and discover novel drug candidates using their AI platform.

Specialties

AI-driven Peptide Drug Discovery Reinforcement Learning Ultra-fast Algorithms Structural Data Integration Peptide Chemistries Therapeutic Peptide Design for Psoriasis and Other Conditions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A1 T: - FT: Series A1	A: 6600000 MR: - FA: $6.6 million FAN: 6600000	D: 2025-01-07 FD: 2025-01-07	1 investors

Series A1 Latest

2025-01-07

$6.6M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

I

Immanuel Lerner

CEO, Co-founder

A

Amit Michaeli

CTO, Co-founder

M

Maayan Elias

CBO, COO | PhD, MBA, BSc. Pharm

T

Tal Kramer

Head of Engineering

S

Shaul Lerner

Head of Biology, PhD

G

Guila Assayag

Senior Scientist & Head of Screening

View 19 more team members with Pro

Unlock Full Team Directory

Recent News

Pepticom Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised